Free tool
Drug Search
Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.
Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations
14 matches for "Avyxa Holdings"
Brand names that start with your search come first, then marketed and novel drugs.
| Drug | Sponsor | Application | First approved | Programs |
|---|---|---|---|---|
| Axtle Pemetrexed Dipotassium | Avyxa Holdings | NDA210661 | Jun 28, 2024 | |
| Axycis Cisplatin | Avyxa Holdings | NDA220748 | Oct 29, 2026 | |
| Avopef Etoposide | Avyxa Holdings | NDA220200 | Feb 13, 2026 | |
| Kyxata Carboplatin | Avyxa Holdings | NDA219921 | Aug 8, 2025 | |
| Oxderys Doxorubicin Hydrochloride | Avyxa Holdings | NDA221093 | Nov 9, 2026 | |
| Favlyxa Fluorouracil | Avyxa Holdings | NDA220201 | Feb 20, 2026 | |
| Vykoura Leucovorin Calcium | Avyxa Holdings | NDA220406 | Feb 3, 2026 | |
| Avgemsi Gemcitabine Hydrochloride | Avyxa Holdings | NDA219920 | Jun 27, 2025 | |
| Posfrea Palonosetron Hydrochloride | Avyxa Holdings | NDA203050 | Mar 1, 2016 | |
| Gobarden Bendamustine Hydrochloride | Avyxa Holdings | NDA219014 | Jul 3, 2025 | |
| Navitrux Fosaprepitant Dimeglumine | Avyxa Holdings | NDA220436 | Jun 24, 2026 | |
| Cligavyx Fulvestrant | Avyxa Holdings | NDA210063 | Aug 19, 2019 | |
| Frindovyx Cyclophosphamide | Avyxa Holdings | NDA210852 | Jun 7, 2023 | |
| Docetaxel Docetaxel | Avyxa Holdings | NDA215813 | Nov 22, 2022 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.